NCT02173548View on ClinicalTrials.gov

Interleukin-1 Blockade in HF With Preserved EF

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

April 11, 2017

Study Completion Date

June 1, 2017

Conditions
Heart Failure With Normal Ejection Fraction
Interventions
DRUG

Anakinra

DRUG

Placebo

Trial Locations (1)

23298

Virginia Commonwealth University, Richmond

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Virginia Commonwealth University

OTHER

NCT02173548 - Interleukin-1 Blockade in HF With Preserved EF | Biotech Hunter | Biotech Hunter